News 2025-09-01
Porton to Showcase Integrated CDMO Expertise at BIOSPAIN 2025

BIOSPAIN is one of the largest biotech events organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and participating companies. In its last edition in 2023, 34% of attendees came from outside Spain, highlighting its truly global reach.
This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of the most dynamic cities in the world.
At Booth 006, Porton will proudly showcase its end-to-end CDMO capabilities across small molecules, peptides & oligonucleotides, biologics & conjugates (ADCs, AOCs, etc.), and advanced therapy medicinal products (ATMPs), backed by stringent quality standards and successful inspections from the FDA, EMA, WHO, PMDA, and NMPA. With a strong focus on innovation, efficiency, and sustainable practices, Porton delivers high-quality solutions supporting drug development from preclinical stages through commercial manufacturing.
Porton Booth:

To schedule an onsite meeting with our BD and scientists' team:
-
Visit our event page by clicking here
-
Email us at: business@portonpharma.com
Our team will be glad to arrange a dedicated session and provide tailored solutions for your needs. Let’s connect and shape the future of biopharma together.
Others
More
News 2026-09-30
Porton Newsletter - September, 2026 Recap
Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001 PMO Therapeutics: Technical Review and Manufacturing Platform Capabilities

News 2026-09-29
Porton Recognized by LyncBio Therapeutics for ADC Payload-Linker CMC Capabilities
Porton, as the project's CDMO partner, completed process development and manufactured non-GMP toxicology batches and GMP clinical trial materials for LYNC-101's payload-linker.